Protracted 5‐fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
Hiroshi Ishii(Chiba Cancer Center), Hiroshi Ikeda(Tokyo National Hospital), Takuji Okusaka(Tokyo National Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Masayoshi Yoshimori(Tokyo National Hospital), Koichi Tokuuye, Shuichi Okada(Tokyo National Hospital), Hiroyasu Nagahama(Kyushu University), Haruhiko Nose(Tokyo National Hospital), Yoshikazu Kagami(Tokyo National Hospital)
Cited by 5
Related Papers
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
|Annals of Oncology|2019|333
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
|Japanese Journal of Clinical Oncology|2017|274
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
|International Journal of Radiation Oncology*Biology*Physics|2001|188